MULPLETA®

Drug Information Related Patent
Hold Company
SHIONOGI INC
Dosage and Administration
TABLET;ORAL
Specification
3MG
Indication
MULPLETA® is used for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo surgery.
API
LUSUTROMBOPAG
API Structure
Drug Patent
Patent NoExpiration Date
76017462024/9/5
85306682030/1/21
88897222028/7/29
94274022031/9/29
API Patent
Patent NoExpiration Date
76017462024/9/5
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top